Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock
1 Articles
1 Articles
Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of United Therapeutics stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $515.03, for a total value of $4,892,785.00. Following the transaction, the chief executive officer directly owned 324,443 shares of the company's stock, valued at $167,097,878.29. The trade was a 2.84% decrease in their posi…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
